No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
作者信息
Cobelens Frank, Gebhard Agnes, van den Hof Susan
机构信息
KNCV Tuberculosis Foundation, The Hague, The Netherlands; Amsterdam Institute for Global Health and Development, Academic Medical Center, Amsterdam, The Netherlands.
KNCV Tuberculosis Foundation, The Hague, The Netherlands.
出版信息
Int J Tuberc Lung Dis. 2016 Feb;20(2):282. doi: 10.5588/ijtld.15.0628.
PMID:26792486
Abstract
摘要
相似文献
1
No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
Int J Tuberc Lung Dis. 2016 Feb;20(2):282. doi: 10.5588/ijtld.15.0628.
2
In reply.
Int J Tuberc Lung Dis. 2016 Feb;20(2):282-3. doi: 10.5588/ijtld.15.0628-2.
3
Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
Int J Tuberc Lung Dis. 2015 Jun;19(6):679-84. doi: 10.5588/ijtld.14.0768.
4
Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
Int J Tuberc Lung Dis. 2012 Feb;16(2):221-3, i-ii. doi: 10.5588/ijtld.11.0266.
5
Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.
Antimicrob Agents Chemother. 2012 Nov;56(11):5465-75. doi: 10.1128/AAC.01300-12. Epub 2012 Aug 6.
6
Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
Clin Infect Dis. 2013 Apr;56(7):1054-5. doi: 10.1093/cid/cis978. Epub 2012 Nov 21.
7
Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.
Tuberculosis (Edinb). 2016 Jul;99:128-130. doi: 10.1016/j.tube.2016.05.003. Epub 2016 May 30.
8
Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
Arch Bronconeumol (Engl Ed). 2019 Jul;55(7):388-390. doi: 10.1016/j.arbres.2018.10.014. Epub 2019 Jan 8.
9
Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
Diagn Microbiol Infect Dis. 2013 Dec;77(4):380-1. doi: 10.1016/j.diagmicrobio.2013.08.014. Epub 2013 Sep 26.
10
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.
Lancet Infect Dis. 2016 Oct;16(10):1185-1192. doi: 10.1016/S1473-3099(16)30190-6. Epub 2016 Jul 7.
引用本文的文献
1
Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00940-17. Print 2017 Aug.
Zotero 插件